TORONTO, Ontario – November 18, 2019 – Novamind Ventures Inc. (“Novamind”) is pleased to announce that it has committed to lead the Synthesis Institute B.V.’s (“Synthesis”) Seed Financing, with a strategic investment of €750,000. Following the close of the investment, Yaron Conforti, Chief Executive Officer of Novamind will join Synthesis’ Board of Directors.
Synthesis is an industry-leading, legal psilocybin retreat center in the Netherlands. Since its inception in 2018, Synthesis has had over 450 participants in its multi-day retreats and has curated an expert team of facilitators, therapists, meditation and breathwork instructors. Synthesis has created an experience that blends the best of ancient practices with modern research for individuals who want to catalyze creative breakthroughs and explore their consciousness.
Before a participant is accepted into one of Synthesis’ programs, they undergo prerequisite health screening to ensure their suitability and safety. Synthesis’ retreats are hosted at a private location 30 minutes from Amsterdam at a venue offering an optimal setting for transformative psychedelic experiences.
Through its investment in Synthesis, Novamind supports the development of psychedelic-assisted psychotherapy protocols, patient screening tools and leading facilitators. Novamind is evaluating a pipeline of early-stage investment opportunities in the psychedelic space and expects to make additional announcements in due course.
About the Synthesis Institute B.V.
Synthesis offers legal, medically supervised psychedelic retreats in the Netherlands. Founded in 2018, it makes psilocybin experiences accessible for curious individuals who want to catalyze creative breakthroughs, explore consciousness, find meaning, improve confidence and search for a mystical experience. For more information visit www.synthesisretreat.com.
Novamind invests in the infrastructure that drives the world’s leading psychedelic clinics and retreats. We seek to accelerate research and innovation in psychedelic medicine by investing in the people, science and technology required for a regulated psychedelics industry. Novamind is building a new standard of mental healthcare. For more information visit www.novamind.ca.
Yaron Conforti, CEO
T: +1 (647) 953 9512